IL-10 is a counter-regulatory cytokine that is secreted in the context of Th2 immunity, and is frequently elevated in progressive hepatic fibrosis.[21–24] The association between IL-10 levels and acute rejection suggests that Th2 tolerance in advanced liver disease pre-LT may paradoxically promote rejection post-LT. This evidence concerns the gene IL10 and liver disorder.